- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04.04. | Bullion Gold Resources Corp (2): Bullion receives TSX-V approval for Bousquet option | 1 | Stockwatch | ||
| 04.04. | Bullion Gold Resources Corporation: Bullion Gold Completes Transaction on Bousquet Property with Olympio Metals and Closes Financing | 1.590 | Newsfile | Montreal, Quebec--(Newsfile Corp. - April 4, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "the Company") announces that the option agreement on the Bousquet property with Olympio... ► Artikel lesen | |
| 28.03. | Bullion Gold Resources Corp (2): Bullion Gold sale of option for Bousquet | 1 | Stockwatch | ||
| BULLION GOLD RESOURCES Aktie jetzt für 0€ handeln | |||||
| 18.03. | Bullion Gold Resources Corp (2): Bullion Gold signs option agreement with Olympio | 1 | Stockwatch | ||
| 18.03. | Bullion Gold Resources Corporation: Bullion Gold Signs Option Agreement with Olympio Metals for the Bousquet Project | 455 | Newsfile | Montreal, Quebec--(Newsfile Corp. - March 18, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "the Company") announces the signing of an option agreement with Olympio Metals ("Olympio"... ► Artikel lesen | |
| 25.02. | Bullion Gold Resources Corp (2): Bullion Gold grants option to sell 80 per cent of Bousquet | 1 | Stockwatch | ||
| 25.02. | Bullion Gold Resources Corporation: Bullion Gold Grants Option on Its Bousquet Project to Olympio Metals | 495 | Newsfile | Montreal, Quebec--(Newsfile Corp. - February 24, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "the Company") announces the signing of a letter of intent with Olympio Metals (ASX:... ► Artikel lesen | |
| 14.01. | Bullion Gold Resources Corp (2): Bullion Gold appoints Morissette as president, CEO | 1 | Stockwatch | ||
| 14.01. | Bullion Gold Resources Corporation: Morissette Joins Bullion Gold to Develop the Bodo Project | 714 | Newsfile | Montreal, Quebec--(Newsfile Corp. - January 14, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "the Company") announces the appointment of Mr. Guy Morissette as President and Chief... ► Artikel lesen | |
| 03.01. | Bullion Gold Resources Corp (2): Bullion Gold closes $448,450 private placement | 1 | Stockwatch | ||
| 03.01. | Bullion Gold Resources Corporation: Bullion Gold Completes Private Placement | 3.364 | Newsfile | Montréal, Québec--(Newsfile Corp. - January 3, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Corporation") announces that it has closed a private placement (the "Offering")... ► Artikel lesen | |
| 04.12.24 | Bullion Gold Resources Corp (2): Bullion Gold appoints Moore, Gervais as directors | 3 | Stockwatch | ||
| 04.12.24 | Bullion Gold Resources Corporation: Moore and Gervais Appointed Directors of Bullion Gold Resources | 868 | Newsfile | Montreal, Quebec--(Newsfile Corp. - December 4, 2024) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is pleased to announce the appointments of MM. Jean-David Moore and... ► Artikel lesen | |
| 13.11.24 | Bullion Gold Resources Corp (2): Bullion Gold arranges $1-million private placement | 1 | Stockwatch | ||
| 13.11.24 | Bullion Gold Resources Corporation: Bullion Prepares $1M Financing and Presents Summary of Its Gold and Polymetallic Projects | 504 | Newsfile | Montreal, Quebec--(Newsfile Corp. - November 13, 2024) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "the Company") will undertake a non-brokered private placement for minimum aggregate... ► Artikel lesen | |
| 27.08.24 | Bullion Gold Resources Corporation: Bullion Gold Bodo Project: Samples Reveal Significant Gold, Silver and Copper Grades | 879 | Newsfile | Montreal, Quebec--(Newsfile Corp. - August 27, 2024) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") announces new sampling results from its Bodo project. Despite the short... ► Artikel lesen | |
| 18.06.24 | Bullion Gold Resources Corporation: Bullion Gold Discovers New Massive Sulphide Zone on Bodo Property, James Bay, Quebec | 347 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 18, 2024) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "The Company") announces that it has completed the first phase of its 2024 exploration... ► Artikel lesen | |
| 14.06.24 | Bullion Gold Resources Corporation: Bullion Closes Private Placement | 452 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 13, 2024) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "The Company") is pleased to announce that it has closed a private placement (the "Offering")... ► Artikel lesen | |
| 03.06.24 | Bullion Gold Resources Corporation: Bullion Hires Momentum PR Firm as Work Begins on Rivon Polymetallic Showing at Bodo Project | 263 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 3, 2024) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "The Company") is pleased to announce that it has retained the services of Momentum PR... ► Artikel lesen | |
| 21.05.24 | Bullion Gold Resources Corporation: Bullion Gold Starts Work on Bodo | 262 | Newsfile | Montreal, Quebec--(Newsfile Corp. - May 21, 2024) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "The Company") will begin an initial exploration program starting June 2024 on its Bodo... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| QIAGEN | 37,020 | -1,57 % | UBS stuft QIAGEN NV auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Qiagen bei einem Kursziel von 48 US-Dollar auf "Neutral" belassen. Die Ziele seien bestätigt worden, nähere Details seien... ► Artikel lesen | |
| SUMMIT THERAPEUTICS | 23,480 | -36,02 % | Summit Therapeutics: Überzeugende Daten - BioNTech gibt ebenfalls mächtig Gas | Die Biotech-Gesellschaft Summit Therapeutics, mit einem Börsenwert von gut 20 Milliarden Dollar kein kleines Unternehmen mehr, kann am Mittwoch erneut über vielversprechende Daten zum großen Hoffnungsträger... ► Artikel lesen | |
| ADMA BIOLOGICS | 21,860 | -2,10 % | ADMA Biologics, Inc.: ADMA Biologics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update | FY 2024 Total Revenue of $426.5 Million, a 65% YoY Increase FY 2024 GAAP Net Income of $197.7 Million, Including an $84.3 Million Valuation Allowance Tax Benefit FY 2024 Adjusted EBITDA(1)... ► Artikel lesen | |
| TARSUS PHARMACEUTICALS | 50,000 | +0,06 % | Tarsus Pharmaceuticals, Inc: Tarsus to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025 | ||
| TEMPUS AI | 52,90 | -1,13 % | Gemeinsam gegen Krebs: Tempus AI, AstraZeneca und Pathos AI entwickeln KI-Modell | CHICAGO, Illinois (IT-Times) - Das Diagnose-Technologie-Unternehmen Tempus AI hat heute bekannt gegeben, zusammen mit AstraZeneca und Pathos AI ein Foundation-Modell im Bereich der Onkologie zu entwickeln.... ► Artikel lesen | |
| SPRINGWORKS THERAPEUTICS | 44,740 | -0,42 % | Hohes Potenzial: Merck KGaA vor Milliarden-Deal: US-Krebsspezialist SpringWorks im Visier | © Foto: Arne Dedert/dpaDer deutsche Pharmakonzern Merck plant den Kauf eines vielversprechenden US-Wettbewerbers. Die Gelegenheit ist günstig.Der Darmstädter Pharma- und Technologiekonzern Merck KGaA... ► Artikel lesen | |
| EVOTEC | 7,382 | +0,52 % | 70 Prozent Kurspotenzial: Evotec überrascht beim Gewinn: Analyst spricht von "ermutigendem Wendepunkt" | © Foto: Breuel-Bild/dpaEvotec hat mit seinen Zahlen für das Geschäftsjahr 2024 zwar bei den Umsätzen keine großen Sprünge gemacht, dafür aber beim Gewinn die Erwartungen übertroffen.Wie Analyst Christian... ► Artikel lesen | |
| BIONTECH | 102,10 | -0,10 % | BioNTech SE: BioNTech veröffentlicht am 5. Mai 2025 Ergebnisse für das erste Quartal 2025 und informiert über operativen Fortschritt | MAINZ, Deutschland, 22. April 2025(Nasdaq: BNTX, "BioNTech" oder "das Unternehmen") wird am Montag, den 5. Mai 2025, die Ergebnisse für das erste Quartal 2025 veröffentlichen. Darüber hinaus wird das... ► Artikel lesen | |
| DYNE THERAPEUTICS | 11,060 | -0,45 % | Dyne Therapeutics, Inc.: Dyne Therapeutics Receives European Medicines Agency (EMA) Orphan Drug Designation for DYNE-251 in Duchenne Muscular Dystrophy | - Recently presented data demonstrated sustained functional improvement with DYNE-251 treatment through 18 months - - Data from the fully enrolled DELIVER registrational expansion cohort is planned... ► Artikel lesen | |
| HARMONY BIOSCIENCES | 29,610 | +0,61 % | JAZZ vs. HRMY: Which Neuroscience Drugmaker Is the Stronger Play? | ||
| VERVE THERAPEUTICS | 5,760 | -0,35 % | Why Verve Therapeutics Zoomed 40% Higher This Week | ||
| RECURSION PHARMACEUTICALS | 5,740 | -0,17 % | Recursion Pharmaceuticals to Report Q1 Earnings: What's in the Cards? | ||
| VIR BIOTECHNOLOGY | 6,120 | -2,70 % | Vir Biotechnology, Inc.: Vir Biotechnology to Present Latest Clinical Data in Hepatitis Delta and B Programs at the European Association for the Study of the Liver (EASL) Congress 2025 | Phase 2 SOLSTICE subgroup analysis data in chronic hepatitis delta selected for poster presentation, and to be highlighted during EASL poster tour 24 Week post-treatment follow-up data... ► Artikel lesen | |
| CG ONCOLOGY | 22,400 | +4,04 % | CG Oncology Inc.: CG Oncology Reports 2024 Year End Financial Results and Provides Business Updates | - Cretostimogene Monotherapy Demonstrated Sustained, Durable Complete Responses in High-Risk Bacillus Calmette Guérin (BCG)-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) - - Initiated... ► Artikel lesen | |
| RELAY THERAPEUTICS | 3,200 | +0,31 % | Relay Therapeutics, Inc.: Relay Therapeutics Announces Updated Interim Data for RLY-2608 + Fulvestrant Demonstrating Continued Maturation of Clinically Meaningful Progression Free Survival | New interim data show 11.4-month median PFS in 2L patients with PI3Ka-mutated, HR+/HER2- metastatic breast cancer at RP2D 39% confirmed ORR across all patients & 67% in patients with kinase mutations... ► Artikel lesen |
BULLION GOLD RESOURCES CORPORATION gehört der Branche Biotechnologie an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BULLION GOLD RESOURCES CORPORATION finden Sie auf Wallstreet Online.
